---
title: "杭州安傑思醫學科技股份有限公司 (688581.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688581.SH.md"
symbol: "688581.SH"
name: "杭州安傑思醫學科技股份有限公司"
industry: "醫療器械"
---

# 杭州安傑思醫學科技股份有限公司 (688581.SH)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 滬深市場 |
| Website | [www.bioags.com](https://www.bioags.com) |

## Company Profile

公司成立于 2010 年。公司秉持 “創造、堅持、分享” 的核心價值觀，為患者和臨床醫生提供更安全、更高效的內鏡微創診療器械，幫助病人減少痛苦，降低醫療成本，公司致力于打造一家"讓員工幸福，客戶滿意，股東放心"的幸福家園，一家受員工尊重、競爭對手尊重以及社會尊重的優秀企業。公司從事內鏡微創診療器械的研發、生產與銷售。主要產品應用于消化內鏡診療領域，按治療用途分為止血閉合類、EMR/ESD 類、活檢類、ERCP 類和診療儀器類。企業榮譽:“浙江省科技小巨人”、“杭州市總部企業”、浙江省知識產權專利示範企業、“浙江省級企業技術中心”、“浙江省生物醫藥高成長型企業”、“浙江省首批 “兩新” 重大科技...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:10.000Z

**Overall: B (0.34)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 21 / 63 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.32% |  |
| Net Profit YoY | 0.53% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.98 |  |
| Dividend Ratio | 2.26% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4.92B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 668.70M |  |


**Multi Score**: B

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 11.41% | B |
| Profit Margin | 40.82% | A |
| Gross Margin | 70.29% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.32% | B |
| Net Profit YoY | 0.53% | C |
| Total Assets YoY | 7.83% | B |
| Net Assets YoY | 8.39% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 244.99% | C |
| OCF YoY | 13.32% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.27 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 4.17% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 杭州安傑思醫學科技股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "11.41%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "40.82%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "70.29%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.32%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "0.53%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.83%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.39%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "244.99%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "13.32%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.27",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "4.17%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 聯影醫療 (SH.688271) | B | B | C | B | B | B |
| 02 | 魚躍醫療 (SZ.002223) | B | B | C | A | C | B |
| 03 | 惠泰醫療 (SH.688617) | A | B | B | A | B | B |
| 04 | 奕瑞科技 (SH.688301) | A | B | E | A | B | B |
| 05 | 振德醫療 (SH.603301) | C | B | C | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 18.04 | 2/66 | 20.53 | 18.37 | 17.45 |
| PB | 1.98 | 10/66 | 2.47 | 2.14 | 1.99 |
| PS (TTM) | 7.36 | 31/66 | 9.16 | 7.93 | 7.42 |
| Dividend Yield | 2.26% | 7/66 | 2.23% | 1.85% | 1.62% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-08-18T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 60.70 |
| Highest Target | 100.00 |
| Lowest Target | 100.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/688581.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688581.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688581.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.